<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Reports of Biochemistry and Molecular Biology</title>
<title_fa></title_fa>
<short_title>rbmb.net</short_title>
<subject>Basic Sciences</subject>
<web_url>http://rbmb.net</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2322-3480</journal_id_issn>
<journal_id_issn_online>2322-3480</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61882/rbmb</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1400</year>
	<month>8</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2021</year>
	<month>11</month>
	<day>1</day>
</pubdate>
<volume>10</volume>
<number>3</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Impact of Berberine on Some Epigenetic, Transcription Regulation and Inflammatory Biomarkers in a Mice Model of Epilepsy</title>
	<subject_fa>بیوشیمی</subject_fa>
	<subject>Biochemistry</subject>
	<content_type_fa>مقالات اصلی</content_type_fa>
	<content_type>Original Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;em&gt;&lt;strong&gt;Background:&lt;/strong&gt;&lt;/em&gt; Epilepsy is one of the most widespread neurological disease worldwide. Status epilepticus&amp;nbsp;(SE) is a life-threatening neurologic disorder. Neuroprotective approaches are increasingly to discover a&amp;nbsp;promising therapy to manage epileptic disorders. This study aimed to assess the impact of berberine on&amp;nbsp;some epigenetic, transcription regulation &amp; inflammatory biomarkers in a mice model of epilepsy.&lt;br&gt;
&lt;br&gt;
&lt;strong&gt;&lt;em&gt;Methods:&lt;/em&gt;&lt;/strong&gt; This work was performed on; Group I: (control), Group II: berberine‐treated control,&amp;nbsp;Group III: epilepsy group, Group IV: berberine‐treated epilepsy. Groups were subjected to&amp;nbsp;assessment of Tumor growth factor-1ꞵ (TGF-1ꞵ), hypoxia inducible factor-1&amp;alpha; (HIF-1&amp;alpha;), brain derived&amp;nbsp;neurotrophic factor (BDNF) levels, histone deacetylase (HDAC) activity &amp; neuronal restrictive silencing&amp;nbsp;factor (NRSF) gene expression.&lt;br&gt;
&lt;br&gt;
&lt;strong&gt;&lt;em&gt;Results:&lt;/em&gt;&lt;/strong&gt; Study showed significant increase in levels of HIF-1&amp;alpha;, TGF-1&amp;beta;, HDAC activity &amp; NRSF gene&amp;nbsp;expression in epilepsy group &amp; decrease in these levels in berberine treated epilepsy group. Significant&amp;nbsp;decrease in BDNF levels in epilepsy &amp; elevation in them in berberine treated epilepsy group.&lt;br&gt;
Conclusions: Our study showed the anti-epileptic impact of berberine via its regulatory effect on some epigenetic,&amp;nbsp;transcription factors &amp; inflammatory biomarkers in a mice model of epilepsy.&amp;nbsp;&lt;/div&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Berberine, Epigenetics, Epilepsy, Transcription regulation & inflammatory biomarkers.</keyword>
	<start_page>362</start_page>
	<end_page>372</end_page>
	<web_url>http://rbmb.net/browse.php?a_code=A-10-703-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Heba Bassiony</first_name>
	<middle_name></middle_name>
	<last_name>Ghanem</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>ghanemhb@yahoo.com.</email>
	<code>100319475328460012517</code>
	<orcid>100319475328460012517</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Clinical laboratory sciences Department, College of Applied Medical Sciences, Jouf University, Sakaka, Saudi Arabia &amp; Medical Biochemistry Department, Faculty of Medicine, Tanta University, Tanta, Egypt.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Marwa Nagy</first_name>
	<middle_name></middle_name>
	<last_name>Emam</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460012518</code>
	<orcid>100319475328460012518</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Physiology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Dareen Abdelaziz Mohammed</first_name>
	<middle_name></middle_name>
	<last_name>Ali</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460012519</code>
	<orcid>100319475328460012519</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Pathology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Rania Nagi</first_name>
	<middle_name></middle_name>
	<last_name>Abd-Ellatif</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460012520</code>
	<orcid>100319475328460012520</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Medical Biochemistry Department, Faculty of Medicine, Tanta University, Tanta, Egypt.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
